167 related articles for article (PubMed ID: 35649719)
21. Missing Self-Induced Microvascular Rejection of Kidney Allografts: A Population-Based Study.
Callemeyn J; Senev A; Coemans M; Lerut E; Sprangers B; Kuypers D; Koenig A; Thaunat O; Emonds MP; Naesens M
J Am Soc Nephrol; 2021 Aug; 32(8):2070-2082. PubMed ID: 34301794
[TBL] [Abstract][Full Text] [Related]
22. Human leukocyte antigen epitope mismatch loads and the development of de novo donor-specific antibodies in cardiothoracic organ transplantation.
Bedford A; Jervis S; Worthington J; Lowe M; Poulton K
Int J Immunogenet; 2022 Feb; 49(1):30-38. PubMed ID: 34904369
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of the presence of anti-human leukocyte antigen-donor specific antibody in kidney transplant recipients with allograft dysfunction.
Chung BH; Kim JH; Choi BS; Park CW; Kim JI; Moon IS; Kim YS; Choi YJ; Oh EJ; Yang CW
Korean J Intern Med; 2018 Jan; 33(1):157-167. PubMed ID: 27764540
[TBL] [Abstract][Full Text] [Related]
24. HLA-DQ mismatches stimulate de novo donor specific antibodies in heart transplant recipients.
Zhang X; Kransdorf E; Levine R; Patel JK; Kobashigawa JA
Hum Immunol; 2020 Jul; 81(7):330-336. PubMed ID: 32307126
[TBL] [Abstract][Full Text] [Related]
25. Class II HLA Eplet Mismatch Is a Risk Factor for De Novo Donor-Specific Antibody Development and Antibody-mediated Rejection in Kidney Transplantation Recipients.
Kishikawa H; Kinoshita T; Hashimoto M; Fukae S; Taniguchi A; Yamanaka K; Nakagawa M; Nishimura K
Transplant Proc; 2018 Oct; 50(8):2388-2391. PubMed ID: 30316363
[TBL] [Abstract][Full Text] [Related]
26. Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney Transplantation.
Morath C; Döhler B; Kälble F; Pego da Silva L; Echterdiek F; Schwenger V; Živčić-Ćosić S; Katalinić N; Kuypers D; Benöhr P; Haubitz M; Ziemann M; Nitschke M; Emmerich F; Pisarski P; Karakizlis H; Weimer R; Ruhenstroth A; Scherer S; Tran TH; Mehrabi A; Zeier M; Süsal C
Front Immunol; 2020; 11():1886. PubMed ID: 32983110
[TBL] [Abstract][Full Text] [Related]
27. HLA-DQ Mismatches and Rejection in Kidney Transplant Recipients.
Lim WH; Chapman JR; Coates PT; Lewis JR; Russ GR; Watson N; Holdsworth R; Wong G
Clin J Am Soc Nephrol; 2016 May; 11(5):875-883. PubMed ID: 27034399
[TBL] [Abstract][Full Text] [Related]
28. Effect of amino acid mismatch in the UNOS dataset.
Sasaki N; El-Awar N; Idica A
Clin Transpl; 2011; ():299-309. PubMed ID: 22755423
[TBL] [Abstract][Full Text] [Related]
29. Expression patterns of B cells in acute kidney transplant rejection.
Carpio VN; Noronha Ide L; Martins HL; Jobim LF; Gil BC; Külzer AS; Loreto Mda S; Gonçalves LF; Manfro RC; Veronese FV
Exp Clin Transplant; 2014 Oct; 12(5):405-14. PubMed ID: 25299368
[TBL] [Abstract][Full Text] [Related]
30. The association between human leukocyte antigen eplet mismatches, de novo donor-specific antibodies, and the risk of acute rejection in pediatric kidney transplant recipients.
Sharma A; Taverniti A; Graf N; Teixeira-Pinto A; Lewis JR; Lim WH; Alexander SI; Durkan A; Craig JC; Wong G
Pediatr Nephrol; 2020 Jun; 35(6):1061-1068. PubMed ID: 32065279
[TBL] [Abstract][Full Text] [Related]
31. Multivariate analysis of the effectiveness of using antibody induction therapy according to the degree of HLA mismatches.
Bunnapradist S; Hong A; Lee B; Takemoto SK
Transplant Proc; 2005 Mar; 37(2):886-8. PubMed ID: 15848565
[TBL] [Abstract][Full Text] [Related]
32. Epitopes as characterized by antibody-verified eplet mismatches determine risk of kidney transplant loss.
Sapir-Pichhadze R; Zhang X; Ferradji A; Madbouly A; Tinckam KJ; Gebel HM; Blum D; Marrari M; Kim SJ; Fingerson S; Bashyal P; Cardinal H; Foster BJ
Kidney Int; 2020 Apr; 97(4):778-785. PubMed ID: 32059998
[TBL] [Abstract][Full Text] [Related]
33. Transplantation results of completely HLA-mismatched living and completely HLA-matched deceased-donor kidneys are comparable.
Laging M; Kal-van Gestel JA; Haasnoot GW; Claas FH; van de Wetering J; Ijzermans JN; Weimar W; Roodnat JI
Transplantation; 2014 Feb; 97(3):330-6. PubMed ID: 24202143
[TBL] [Abstract][Full Text] [Related]
34. Impact of HLA eplet mismatch load in immunological outcomes after living donor kidney transplantation.
Alves TA; Nascimento E; de Castro LB; Fabreti-Oliveira RA
Transpl Immunol; 2023 Oct; 80():101908. PubMed ID: 37536379
[TBL] [Abstract][Full Text] [Related]
35. Markers of graft microvascular endothelial injury may identify harmful donor-specific anti-HLA antibodies and predict kidney allograft loss.
Louis K; Hertig A; Taupin JL; Buob D; Jamme M; Brocheriou I; Luque Y; Jouanneau C; Ouali N; Audouin M; Rondeau E; Xu-Dubois YC
Am J Transplant; 2019 Sep; 19(9):2434-2445. PubMed ID: 30836425
[TBL] [Abstract][Full Text] [Related]
36. Time course of pathologic changes in kidney allografts of positive crossmatch HLA-incompatible transplant recipients.
Bagnasco SM; Zachary AA; Racusen LC; Arend LJ; Carter-Monroe N; Alachkar N; Nazarian SM; Lonze BE; Montgomery RA; Kraus ES
Transplantation; 2014 Feb; 97(4):440-5. PubMed ID: 24531821
[TBL] [Abstract][Full Text] [Related]
37. Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection.
Kikić Ž; Kainz A; Kozakowski N; Oberbauer R; Regele H; Bond G; Böhmig GA
Clin J Am Soc Nephrol; 2015 Aug; 10(8):1435-43. PubMed ID: 26071493
[TBL] [Abstract][Full Text] [Related]
38. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C
Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738
[TBL] [Abstract][Full Text] [Related]
39. Significance of HLA-matching and anti-HLA antibodies in heart transplant patients receiving induction therapy?
Gavroy B; Timmermans T; Van Caenegem O; Mastrobuoni S; Jacquet L; Latinne D; Poncelet AJ
Transpl Immunol; 2022 Dec; 75():101706. PubMed ID: 36113729
[TBL] [Abstract][Full Text] [Related]
40. Clinical and pathological analyses of transplant glomerulopathy cases.
Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]